Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide

Tamara R Anderegg et al. J Clin Microbiol. 2004 Mar.

. 2004 Mar;42(3):1386-7.

doi: 10.1128/JCM.42.3.1386-1387.2004.

No abstract available

References

1. Finlay, J. E., L. A. Miller, and J. A. Poupard. 1997. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother. 41:1137-1139. - PMC - PubMed
1. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. W. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092. - PMC - PubMed
1. National Committee for Clinical Laboratory Standards. 2001. Development of in vitro susceptibility testing criteria and quality control parameters. Approved standard M23-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
1. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth microdilution antifungal susceptibility testing of yeasts. Approved standard, M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
1. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6, 6th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.